GlycoMimetics, Inc.
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inh…
Biotechnology
US, Rockville [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
GlycoMimetics, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDGlycoMimetics, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of GlycoMimetics, Inc..
If you want to see a demo, head over to the financial segments of AAPL